Feedback / Questions
gemcitabine/docetaxel controlled release (NDV-01) - Relmada Therapeutics
https://www.globenewswire.com/news-release/2025/08/07/3129672/0/en/Relmada-Therapeutics-Reports-Second-Quarter-2025-Financial-Results-and-Announces-NDV-01-6-Month-Follow-up-Safety-and-Efficacy-Data-in-NMIBC.html
Aug 7, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next